Prime Medicine, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2021 | — | — | $200.7M |
| Dec 2021 | $62.3M | $301.9M | $185.4M |
| Mar 2022 | — | — | $164.2M |
| Jun 2022 | — | — | $92.2M |
| Sep 2022 | $42.6M | $215.3M | $47.9M |
| Dec 2022 | $44.0M | $360.3M | $187.6M |
| Mar 2023 | $38.1M | $316.9M | $133.5M |
| Jun 2023 | $40.8M | $280.9M | $120.6M |
| Sep 2023 | $45.2M | $239.1M | $44.0M |
| Dec 2023 | $60.8M | $193.9M | $41.6M |
| Mar 2024 | $67.6M | $311.4M | $94.2M |
| Jun 2024 | $63.1M | $259.7M | $55.6M |
| Sep 2024 | $143.3M | $332.8M | $118.0M |
| Dec 2024 | $144.4M | $297.5M | $182.5M |
| Mar 2025 | $221.2M | $328.2M | $91.9M |
| Jun 2025 | $218.1M | $279.0M | $53.8M |
| Sep 2025 | $223.2M | $385.0M | $71.4M |
| Dec 2025 | $221.9M | $342.7M | $63.0M |
| Mar 2026 | $218.0M | $294.7M | $64.1M |
| Jun 2026 | $209.2M | $249.0M | $47.5M |
Mimicking the herd invites regression to the mean (merely average performance).